Apotex Health Corp. (TSX:APTX)

Canada · Delayed Price · Currency is CAD

37.19

-0.19 (-0.51%)

At close: Aug 10, 2026

Apotex Health Financials Overview

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	3,491	3,491	3,350	2,940
Revenue Growth	-	4.21%	13.92%	-
Gross Profit	1,943	1,943	1,820	1,322
Operating Income	1,070	1,070	997.98	628.71
Net Income	373.78	373.78	151.7	-146.92
Earnings Per Share	1.91	1.91	0.80	-0.82
EPS Growth	-	139.14%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Conventional Generics	1,781	1,781	1,872	1,786
Specialty Generics	1,151	1,151	976.3	784.21
Brands & Biosimilars	558.7	558.7	500.96	369.76
Total	3,491	3,491	3,350	2,940

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Cash & Investments	56.99	56.99	77.97	421.35
Total Debt	3,521	3,521	2,650	1,874
Net Cash (Debt)	-3,464	-3,464	-2,572	-1,452
Net Cash Growth	-	-	-	-
Net Cash Per Share	-17.94	-17.94	-13.56	-8.12

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Operating Cash Flow	640.96	640.96	554.41	570.9
Capital Expenditures	-121.06	-121.06	-93.58	-83.26
Free Cash Flow	519.9	519.9	460.84	487.65
Free Cash Flow Growth	-	12.82%	-5.50%	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Gross Margin	55.65%	55.65%	54.34%	44.97%
Operating Margin	30.65%	30.65%	29.79%	21.38%
Pretax Margin	14.89%	14.89%	9.27%	-5.29%
Profit Margin	10.71%	10.71%	4.53%	-5.00%
FCF Margin	14.89%	14.89%	13.76%	16.58%